Par Drugs and Chemicals Limited - Laporan Laba Rugi (TTM)

Par Drugs and Chemicals Limited
IN ˙ NSEI
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Par Drugs and Chemicals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 550 579 608 631 686 692 751 821 873 933 957 952 962 973 956 953 1,041 1,015 1,010 1,044
Change (%) 5.28 4.91 3.87 8.65 0.94 8.48 9.35 6.36 6.89 2.58 -0.60 1.12 1.11 -1.72 -0.34 9.20 -2.52 -0.48 3.41
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 219 227 225 233 248 252 293 340 376 414 410 392 384 360 347 316 355 365 381 420
Change (%) 3.67 -1.05 3.57 6.50 1.39 16.53 16.05 10.62 10.01 -1.01 -4.38 -1.93 -6.26 -3.82 -8.79 12.37 2.68 4.55 10.10
% of Revenue 39.87 39.26 37.03 36.93 36.19 36.35 39.05 41.44 43.10 44.36 42.80 41.18 39.93 37.02 36.23 33.16 34.13 35.95 37.76 40.20
Gross Operating Profit 331 352 383 398 437 440 458 481 497 519 548 560 578 613 610 637 686 650 628 624
Change (%) 6.35 8.76 4.05 9.92 0.68 3.88 5.07 3.35 4.53 5.45 2.23 3.26 6.00 -0.48 4.45 7.63 -5.21 -3.31 -0.65
% of Revenue 60.13 60.74 62.97 63.07 63.81 63.65 60.95 58.56 56.90 55.64 57.20 58.82 60.07 62.98 63.77 66.84 65.87 64.05 62.24 59.80
SG&A 38 38 40 40 41 41 41 42 42 46 49 51 52 53 55 56 58 57 59 60
Change (%) 0.05 4.33 0.38 2.30 -0.31 0.71 1.78 1.76 7.38 7.16 3.39 2.65 1.78 4.15 2.53 3.40 -1.90 2.33 2.70
% of Revenue 6.93 6.58 6.55 6.33 5.96 5.88 5.46 5.08 4.86 4.89 5.10 5.31 5.39 5.43 5.75 5.92 5.60 5.64 5.80 5.76
R&D
Change (%)
% of Revenue
OpEx 445 462 476 498 552 563 621 695 729 792 808 799 794 786 763 759 807 819 851 892
Change (%) 3.83 2.92 4.62 10.89 2.06 10.28 11.90 4.95 8.66 1.93 -1.13 -0.57 -1.02 -2.98 -0.47 6.30 1.53 3.91 4.83
% of Revenue 80.91 79.80 78.28 78.85 80.47 81.37 82.72 84.64 83.52 84.90 84.36 83.91 82.50 80.77 79.74 79.63 77.52 80.73 84.30 85.46
Operating Income 105 117 132 133 134 129 130 126 144 141 150 153 168 187 194 194 234 195 159 152
Change (%) 11.41 12.76 1.17 0.31 -3.70 0.61 -2.81 14.13 -2.07 6.25 2.28 9.94 11.14 3.56 0.16 20.53 -16.45 -18.89 -4.25
% of Revenue 19.09 20.20 21.72 21.15 19.53 18.63 17.28 15.36 16.48 15.10 15.64 16.09 17.50 19.23 20.26 20.37 22.48 19.27 15.70 14.54
Interest Expense -7 -6 -6 -5 -5 -6 -4 -4 -2 -1 -0 -1 -1 -0 -0 -1 -1
Change (%) -17.67 9.17 -22.30 12.94 9.45 -34.95 3.53 -50.90 -36.26 -98.03 4,150.00 -93.81 -78.26 5,373.33 -4.38
% of Revenue -1.22 -0.95 -0.99 -0.74 -0.77 -0.84 -0.50 -0.47 -0.22 -0.13 -0.00 -0.11 -0.12 -0.01 -0.00 -0.08 -0.08
Net Income 83 88 116 115 112 112 92 91 106 103 113 115 127 142 145 146 183 154 134 142
Change (%) 5.97 32.21 -0.86 -2.91 0.29 -17.80 -1.75 16.62 -2.34 9.94 1.53 10.14 12.26 1.91 0.45 25.43 -15.57 -13.41 5.95
% of Revenue 15.07 15.17 19.11 18.24 16.30 16.20 12.27 11.03 12.09 11.05 11.84 12.09 13.17 14.62 15.16 15.28 17.55 15.20 13.23 13.55

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista